Stem cell therapies can recover TP enzyme function and improve the prognosis of MNGIE patients, which provides the initial evidence to support the effects of stem cell therapy in mitochondrial encephalomyopathy.20, 21, 22, 23. This evidence concerns the gene TYMP and mitochondrial neurogastrointestinal encephalomyopathy.